MGIA
CATX icon

Moneta Group Investment Advisors’s Perspective Therapeutics CATX Stock Holding History

Moneta Group Investment Advisors’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.9K Hold
23,707
– – ﹤0.01% 782
2025
Q4 		$65.2K Hold
23,707
– – ﹤0.01% 798
2025
Q3 		$81.3K Hold
23,707
– – ﹤0.01% 778
2025
Q2 		$81.6K Hold
23,707
– – ﹤0.01% 693
2025
Q1 		$50.5K Hold
23,707
– – ﹤0.01% 657
2024
Q4 		$75.6K Hold
23,707
– – ﹤0.01% 652
2024
Q3 		$316K Hold
23,707
– – ﹤0.01% 506
2024
Q2 		$236K Buy
23,707
+21,336
+900% +$308K ﹤0.01% 542
2024
Q1 		$282K Buy
+2,371
New +$20.2K ﹤0.01% 504

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Moneta Group Investment Advisors's CATX Position: Q1 2026 in Review

Moneta Group Investment Advisors held its Perspective Therapeutics (CATX) position steady in Q1 2026 at 23,707 shares worth $98.9K. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Moneta Group Investment Advisors first reported a position in CATX in Q1 2024 and has held it in 9 quarters since. The position peaked at $316K in Q3 2024. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Moneta Group Investment Advisors held 23,707 shares of Perspective Therapeutics worth $98.9K as of Q1 2026.
  • Moneta Group Investment Advisors left its Perspective Therapeutics share count unchanged in Q1 2026.
  • Perspective Therapeutics made up ﹤0.01% of Moneta Group Investment Advisors's portfolio in Q1 2026, its #782 holding.
  • Moneta Group Investment Advisors first reported a position in Perspective Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Moneta Group Investment Advisors's Perspective Therapeutics position peaked at $316K in Q3 2024.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Moneta Group Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.